Paper684036
Multicompartmental analysis of serum, urine and bile concentrations of rifampicin and desacetyl-rifampicin in subjects treated for one week.
Acocella G and 2 others. Pharmacol Res Commun, 1978. Cited by 36 papers, by iCite.
Cite this record
ConductScience Library. Multicompartmental analysis of serum, urine and bile concentrations of rifampicin and desacetyl-rifampicin in subjects treated for one week. Papers, record 684036. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/684036
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Multicompartmental analysis of serum, urine and bile concentrations of rifampicin and desacetyl-rifampicin in subjects treated for one week.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Rifampin | Major topic |
| Bile | |
| Chromatography, Thin Layer | |
| Dealkylation | |
| Female | |
| Humans | |
| Kinetics | |
| Models, Biological | |
| Time Factors |
Source PubMed
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41787130 | In Silico Comparison of Rifampicin and 25-desacetyl Rifampicin-Induced PXR-Mediated CYP450 Transcriptional Response in 3D Primary Human Hepatocytes. | Bull Math Biol | 2026 | https://conductscience.org/library/papers/41787130 | PubMed |
| 37705216 | Various effects of repeated rifampin dosing on coproporphyrin levels in humans. | Clin Transl Sci | 2023 | https://conductscience.org/library/papers/37705216 | PubMed |
| 37324091 | Oral rifampicin interferes with urine dipstick tests for patients with pulmonary tuberculosis. | J Thorac Dis | 2023 | https://conductscience.org/library/papers/37324091 | PubMed |
| 29368402 | Comprehensive PBPK Model of Rifampicin for Quantitative Prediction of Complex Drug-Drug Interactions: CYP3A/2C9 Induction and OATP Inhibition Effects. | CPT Pharmacometrics Syst Pharmacol | 2018 | https://conductscience.org/library/papers/29368402 | PubMed |
| 26055359 | Pharmacokinetic Modeling and Optimal Sampling Strategies for Therapeutic Drug Monitoring of Rifampin in Patients with Tuberculosis. | Antimicrob Agents Chemother | 2015 | https://conductscience.org/library/papers/26055359 | PubMed |
| 22472995 | Safety and pharmacokinetics of escalating daily doses of the antituberculosis drug rifapentine in healthy volunteers. | Clin Pharmacol Ther | 2012 | https://conductscience.org/library/papers/22472995 | PubMed |
| 18391026 | Population pharmacokinetics of rifampin in pulmonary tuberculosis patients, including a semimechanistic model to describe variable absorption. | Antimicrob Agents Chemother | 2008 | https://conductscience.org/library/papers/18391026 | PubMed |
| 15762766 | Pharmacokinetic considerations in the treatment of tuberculosis in patients with renal failure. | Clin Pharmacokinet | 2005 | https://conductscience.org/library/papers/15762766 | PubMed |
| 6721995 | Rifampicin kinetics in undernutrition. | Br J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6721995 | PubMed |
| 6615687 | Hepatic enzyme induction and leucocyte delta-aminolaevulinic acid synthase activity: studies with carbamazepine. | Br J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6615687 | PubMed |
| 6391781 | Clinical pharmacokinetics of the antituberculosis drugs. | Clin Pharmacokinet | 1984 | https://conductscience.org/library/papers/6391781 | PubMed |
| 6318788 | Pharmacokinetic studies of cimetidine and ranitidine before and after treatment in peptic ulcer patients. | Br J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6318788 | PubMed |
| 6113907 | Clinical implications of enzyme induction and enzyme inhibition. | Clin Pharmacokinet | 1981 | https://conductscience.org/library/papers/6113907 | PubMed |
| 4087830 | Pharmacokinetics of oral and intravenous rifampicin during chronic administration. | Klin Wochenschr | 1985 | https://conductscience.org/library/papers/4087830 | PubMed |
| 4027118 | Pharmacokinetics of primaquine in man. II. Comparison of acute vs chronic dosage in Thai subjects. | Br J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/4027118 | PubMed |
| 2044328 | Nonlinear pharmacokinetics: clinical Implications. | Clin Pharmacokinet | 1991 | https://conductscience.org/library/papers/2044328 | PubMed |
| 346286 | Clinical pharmacokinetics of rifampicin. | Clin Pharmacokinet | 1978 | https://conductscience.org/library/papers/346286 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/684036
GET https://conductscience.org/api/papers/v1/684036/authors